Coronavirus Disease 2019 (COVID-19)

ARUP will continue to support you by providing quality COVID-19 testing and up-to-date information so that you can make the best decisions for your patients.

COVID-19 Diagnostic and Antibody Tests

We offer nucleic acid amplification (NAA) testing for the diagnosis of COVID-19 infection and two immunoglobulin G (IgG) antibody tests to evaluate for exposure to SARS-CoV-2.

COVID-19 Test Information
 

 

For Clinicians, Hospitals, and Labs

Testing options, specimen collection requirements, decision support tools, and testing guidelines

 

Frequently Asked Questions

Which test to choose, how tests differ, and how to interpret them

ARUP’s molecular COVID-19 assay (SARS-CoV-2 (COVID-19) by NAA, 3002638) and SARS-CoV-2 antibody tests (COVID-19 IgG (Spike), Semi-Quantitative by CIA, 3003648 and COVID-19 IgG, Qualitative by CIA, 3002776) are offered under U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA). Please visit the FDA web page, EUA Authorized Serology Test Performance, for more information.

COVID-19 Expertise and Support

solutions-workflow Operational Assistance

Contact your account executive today to find out how ARUP can support you.

 

gear-idea Clinical Trials Support

Our Pharma Services experts are ready to support your COVID-19-related clinical trials.

 

people-management Healthcare Advisory Services

From workflow to outreach, we can help you navigate the new normal of your lab business.

  Find Out How ARUP Can Support You

 

Your Trusted Healthcare Partner

ARUP remains committed to providing quality testing and up-to-date guidance so that you can continue to provide the best patient care.